Schroeder E Todd, Vallejo Alberto F, Zheng Ling, Stewart Yolanda, Flores Carla, Nakao Susie, Martinez Carmen, Sattler Fred R
Department of Biokinesiology & Physical Therapy, University of Southern California, Los Angeles, CA 90089, USA.
J Gerontol A Biol Sci Med Sci. 2005 Dec;60(12):1586-92. doi: 10.1093/gerona/60.12.1586.
The purpose of our study was to assess the early effects of a potent anabolic androgen on muscle mass and strength, lower extremity power, and functional performance in older men.
Thirty-two men 72 +/- 6 years of age were randomized to receive oxandrolone (10 mg twice daily) or matching placebo in a 2:1 manner for 12 weeks. Total and appendicular lean body mass (LBM) were assessed by dual-energy x-ray absorptiometry (DEXA). Lower extremity muscle volume was determined by magnetic resonance imaging to validate DEXA changes.
Total LBM increased by 2.7 +/- 1.6 kg after 6 weeks with oxandrolone (p <.001), which was greater (p <.001) than the decline in LBM (-0.5 +/- 0.9 kg) with placebo. Appendicular LBM increased by 1.2 +/- 0.9 kg after just 6 weeks with oxandrolone (p <.001), which was greater (p <.001) than the decline in LBM (-0.4 +/- 0.5 kg) with placebo. These changes were >90% of the gains in total and appendicular LBM (3.0 +/- 1.5 kg and 1.3 +/- 0.9 kg, respectively) after 12 weeks. Total thigh and hamstring muscle volume increased by 111 +/- 29 mm(3) (p =.001) and 75 +/- 18 mm(3) (p =.001), respectively, after 12 weeks. Maximal strength increased for the leg press 6.3 +/- 5.6% (p =.003), leg curl 6.7 +/- 8.6% (p =.01), chest press 6.9 +/- 6.5% (p =.001), and latissimus pull-down 4.8 +/- 6.3% (p =.009) with oxandrolone after 6 weeks; these increases were different than those with placebo (p <.001) and were 93%, 96%, 74%, and 94% of the respective gains at week 12. There were no improvements in functional measures.
Treatment with a potent anabolic androgen may produce significant increases in muscle mass and strength after only 6 weeks in healthy older men. However, such treatment did not improve leg muscle power or walking speed.
我们研究的目的是评估一种强效合成代谢雄激素对老年男性肌肉量和力量、下肢功率及功能表现的早期影响。
32名年龄在72±6岁的男性以2:1的比例随机分组,分别接受氧雄龙(每日两次,每次10毫克)或匹配的安慰剂,为期12周。通过双能X线吸收法(DEXA)评估总体和附属瘦体重(LBM)。通过磁共振成像确定下肢肌肉体积,以验证DEXA的变化。
使用氧雄龙6周后,总体LBM增加了2.7±1.6千克(p<.001),这比使用安慰剂时LBM的下降(-0.5±0.9千克)更大(p<.001)。仅使用氧雄龙6周后,附属LBM增加了1.2±0.9千克(p<.001),这比使用安慰剂时LBM的下降(-0.4±0.5千克)更大(p<.001)。这些变化分别是12周后总体和附属LBM增加量(分别为3.0±1.5千克和1.3±0.9千克)的90%以上。12周后,大腿和腘绳肌总体积分别增加了111±29立方毫米(p=.001)和75±18立方毫米(p=.001)。使用氧雄龙6周后,腿举的最大力量增加了6.3±5.6%(p=.003),腿弯举增加了6.7±8.6%(p=.01),卧推增加了6.9±6.5%(p=.001),背阔肌下拉增加了4.8±6.3%(p=.009);这些增加与使用安慰剂时不同(p<.001),且分别是第12周相应增加量的93%、96%、74%和94%。功能指标没有改善。
在健康老年男性中,使用强效合成代谢雄激素治疗仅6周后,肌肉量和力量可能会显著增加。然而,这种治疗并未改善腿部肌肉功率或步行速度。